Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2024-11-18

Clinical Trial Update: TheraPAP Adherence Crossover Study [NA]

View source ↗

Summary

A clinical trial update announcing the withdrawal of the TheraPAP Adherence Crossover Study for obstructive sleep apnea.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TheraPAP

Snippet

Sponsor: SleepRes Inc. | Conditions: Obstructive Sleep Apnea | NA | Status: WITHDRAWN